Zhongshan Laibo Ruichen Biomedicine Co., Ltd.

Home>

RAB001 Receives Phase II Clinical Trial Approval!

Rabpharma Clinches First Prize in Guangdong! Triumph at 2024 China Innovation & Entrepreneurship Competition!

Zhongshan Rabpharma Biopharmaceutical Co., Ltd. Approved to Establish Guangdong Provincial Doctoral Workstation

Rabpharma Designated as 2023 Guangdong Specialized, Sophisticated, Distinctive and Innovative SME

Rabpharma Closes Series A+ Round with Strategic Investors to Accelerate Oncology Pipeline